Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04006431
Other study ID # Local/2018
Secondary ID
Status Completed
Phase
First received
Last updated
Start date April 4, 2019
Est. completion date April 4, 2020

Study information

Verified date July 2019
Source Centre Hospitalier Universitaire de Nimes
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Prostate embolization is an alternative treatment to trans urethral prostate resection in the context of benign prostatic hypertrophy. This embolization treatment is also of interest in patients with chronic anuria surveyed in relation to their prostatic hypertrophy for disundation. This survey causes discomfort and urinary tract infection. It is a population with tortuous arteries, a severe atherosclerotic overload making embolizations complex and long. Often, only unilateral embolization is possible. The purpose of this study is to compare the effectiveness in terms of disundation of unilateral vs. bilateral embolization of the prostatic arteries


Description:

Prostate embolization is an alternative treatment to trans urethral prostate resection in the context of benign prostatic hypertrophy. This embolization treatment is also of interest in patients with chronic anuria surveyed in relation to their prostatic hypertrophy for disundation. This survey causes discomfort and urinary tract infection. It is a population with tortuous arteries, a severe atherosclerotic overload making embolizations complex and long. Often, only unilateral embolization is possible. The purpose of this study is to compare the effectiveness in terms of disundation of unilateral vs. bilateral embolization of the prostatic arteries.

Method of observation or investigation chosen:

Retrospective, observational collection with division of patients into two groups according to unilateral or bilateral embolization of the porstatic arteries.

Origin and nature of the data Patient's medical record: imaging stored in the PACS to confirm unilateral or bilateral embolization, perform measurements of prostate volume, urological medical record to see the effectiveness of embolization in terms of disundation, comfort of life, tolerance of embolization, effectiveness in terms of urination (IPSS score)

Data flow mode:

Data stored in redcap.


Recruitment information / eligibility

Status Completed
Enrollment 50
Est. completion date April 4, 2020
Est. primary completion date April 4, 2020
Accepts healthy volunteers
Gender All
Age group 70 Years and older
Eligibility Inclusion Criteria:

- Elderly patients (>70 years old)

- with contraindications to surgery,

- with a chronic urinary catheterization

Exclusion Criteria:

- <70 years old

- without contraindications to surgery

- without chronic urinary catheterization

Study Design


Related Conditions & MeSH terms

  • Unilateral vs Bilateral Embolization of the Prostate Arteries

Intervention

Other:
embolization
Retrospective, observational collection with division of patients into two groups according to unilateral or bilateral embolization of the porstatic arteries.

Locations

Country Name City State
France CHU de Nîmes Nîmes

Sponsors (1)

Lead Sponsor Collaborator
Centre Hospitalier Universitaire de Nimes

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary the effectiveness of embolization International prostate score symptomsScore at one month